We, based on knowledge from developmental biology and published research, developed an optimized protocol to efficiently generate A9 midbrain dopaminergic neurons from both human embryonic stem cells and human induced pluripotent stem cells, which would be useful for disease modeling and cell replacement therapy for Parkinson’s disease.
Zhang, P., Xia, N., Reijo Pera, R. A. Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells. J. Vis. Exp. (91), e51737, doi:10.3791/51737 (2014).